Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Angela W.F. On"'
Autor:
Yea Huei K.ao Yang, Maggie M.eng Yu Weng, Ching Lan Cheng, Pi Huei Chao, Angela W.F. On, Jason C. Hsu
Publikováno v:
Pharmacoepidemiology and Drug Safety. 23:309-313
Objective The purpose of this study is to evaluate the utilization of four approved antihyperuricemic agents in Taiwan before and after two safety announcements rescinded an indication for allopurinol and added a warning on benzbromarone-induced hepa
Autor:
Angela W.F. On, Mei Ling Hsiao, Cindy Liu, Kuo Hwa Lin, Hsueh Yung Tai, Yu Wen Huang, Lan Hui Chih
Publikováno v:
Journal of Pharmaceutical Health Services Research. 3:3-9
Taiwan operates a unique no-fault compensation-based scheme for injuries caused by medication use. This article describes the operation of the Taiwan Drug Relief Foundation and some results since the Taiwan Drug Hazard Relief Act was enacted in 2000.
Autor:
Cheng, Ching‐Lan, Chao, Pi‐Huei, Hsu, Jason Chih‐Sheng, Weng, Maggie Meng‐Yu, On, Angela W.F., Yang, Yea‐Huei Kao
Publikováno v:
Pharmacoepidemiology & Drug Safety; Mar2014, Vol. 23 Issue 3, p309-313, 5p
Autor:
On, Angela W.F., Chih, Lan Hui, Liu, Cindy, Lin, Kuo Hwa, Huang, Yu Wen, Tai, Hsueh Yung, Hsiao, Mei Ling
Publikováno v:
Journal of Pharmaceutical Health Services Research; Mar2012, Vol. 3 Issue 1, p3-9, 7p
Publikováno v:
Journal of Food and Drug Analysis; September 2014, Vol. 22 Issue: 3 p356-362, 7p
Publikováno v:
Journal of Food and Drug Analysis, Vol 22, Iss 3, Pp 356-362 (2014)
Antituberculosis drug-related liver injury (ATLI) is the most prevalent hepatotoxicity in many countries. Whether monitoring liver tests is beneficial to prevent this potentially grave adverse drug reaction (ADR) is open to debate. The Taiwan Drug Re